Procyrion, Inc.

  The countdown to HFSA 2024 has begun! Our team will be at the HFSA Devices in Heart Failure Meeting this Friday, September 27. Stop by to learn more about the Aortix pMCS and our ongoing DRAIN-HF study for patients with acute decompensated heart failure. #HFSA #heartfailure #cardiorenalsyndrome #cardiology #Aortix #innovation

Want to learn more about the safety and performance of the Aortix pump in patients with acute decompensated heart failure? Check out the results from our Cardiorenal Syndrome pilot study published in #JACCHF.  https://lnkd.in/gdrEym56   #cardiorenalsyndrome #Aortix #innovation #heartfailure #cardiology

New DRAIN-HF site alert! Congrats to the team at Atrium Health led by Drs. Shuktika Nandkeolyar, MD and Nyal Borges on enrolling your first patient in this groundbreaking study for patients with acute decompensated heart failure. We are grateful for your commitment to advance treatment options for #heartfailure patients! #Aortix #cardiorenalsyndrome #diureticresistance #clinicaltrials #innovation 

Welcome Lucas Buchanan to the Procyrion Board! Lucas is the Chief Operating Officer and Chief Financial Officer at Silk Road Medical, Inc. and brings over two decades of expertise in commercialization, operations, business development, and finance. His insights will be of tremendous value as we work to complete enrollment in the DRAIN-HF trial and prepare for commercialization of the #Aortix technology. #leadership #innovation #medtech #cardiology #heartfailure #cardiorenalsyndrome

Will you be attending HFSA in Atlanta? The Procyrion team will be at the HFSA Devices in Heart Failure Meeting on September 27 and can't wait to meet with you. Stop by to learn more about Aortix pMCS and our ongoing DRAIN-HF IDE study for patients with acute decompensated heart failure. #HFSA #heartfailure #cardiorenalsyndrome #cardiology #Aortix #innovation

First DRAIN-HF enrollment in North Carolina! Congrats to Dr. Marat Fudim and the team at Duke University Health System on enrolling your first patient in this groundbreaking trial of Aortix for #heartfailure patients. #Aortix #cardiorenalsyndrome #diureticresistance #clinicaltrials #innovation

We’re excited to announce that Dr. Joggy George and the team at The Texas Heart Institute have enrolled 2 patients in the groundbreaking DRAIN-HF study! Thank you for your commitment to advance treatment options for patients with acute decompensated #heartfailure.   #Aortix #cardiorenalsyndrome #diureticresistance #clinicaltrials #innovation

First DRAIN-HF enrollment in Ohio! Congrats to Dr. Indra Bole (Indra B.) and the dedicated team at Ohio State University on enrolling your first patient in this groundbreaking study. We look forward to working with you to advance treatment options for patients with acute decompensated #heartfailure.   #Aortix #cardiorenalsyndrome #diureticresistance #clinicaltrials #innovation

First DRAIN-HF enrollment in Oregon! Congratulations to Jeffrey Marbach and the team at Oregon Health & Science University on enrolling your first patient in this groundbreaking study for patients with acute decompensated #heartfailure. #Aortix #cardiorenalsyndrome #diureticresistance #clinicaltrials #innovation Also pictured are Aaron Palmer and Ann Hammes from the Procyrion side!

We’re excited to announce Dr. Oliver G. Abela, MD, FACC and the team at AdventHealth Tampa have enrolled their first patient in the groundbreaking DRAIN-HF trial. Thank you for your commitment to advance treatment options for patients with acute decompensated #heartfailure!   #Aortix #cardiorenalsyndrome #diureticresistance #clinicaltrials #innovation